Navigation Links
Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
Date:3/26/2013

60;

A telephonic replay of the call will be available for 30 days beginning at 8:00 p.m. ET on March 26, 2013.  Access numbers for this replay are 1-877-344-7529 (U.S./Canada) and 1-412-317-0088 (international); conference ID: 10026445.  The webcast replay will remain available in the Investors Relations section of the Venaxis web site for 30 days.

About Venaxis, Inc.
Venaxis, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its rapid, protein biomarker-based appendicitis test, APPY1.  This unique appendicitis test has projected high sensitivity and negative predictive value and is being developed to aid in the identification of patients at low risk for acute appendicitis, allowing for more conservative patient management.  APPY1 is CE Marked in Europe and is being developed in the U.S. initially for pediatric, adolescent and young adult patients with abdominal pain, as this population is at the highest risk for appendicitis and has the highest risk of long-term health effects associated with CT imaging.  While FDA clearance is being sought, an initial launch for APPY1 is ongoing in select European territories.  For more information, visit www.venaxis.com.

Forward-Looking Statements
This press release includes "forward-looking statements" of Venaxis, Inc. ("Venaxis") as defined by the Securities and Exchange Commission ("SEC"). All statements, other than statements of historical fact, included in this press release that address activities, events or developments that Venaxis believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors Venaxis believes are appropriate in the circumstances. Such
'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AspenBio Pharma Changes Company Name to Venaxis, Inc.
2. Venaxis to Present at 2013 BIO CEO and Investor Conference
3. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
4. Venaxis to Present at 25th Annual ROTH Conference
5. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
6. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
7. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
8. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
9. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
10. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
11. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015  Research ... addition of the "An Introduction to the ... 2015)" conference to their offering. ... the European medical device legislation. It will explain ... involvement of Notified Bodies, how to choose one ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has ... Legislation (London, UK - November 16-17, 2015)" conference ... EU modules concerning Pharmacovigilance are a major departure in ... Europe . The intention of the course ... examine how they overlap and fit together and what ...
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2
... , , HOUSTON, Nov. 16 Cyberonics, Inc. ... to its tax position. , In its fiscal second quarter ... GAAP tax benefit of approximately $40 million resulting from the ... losses. The recognition of this tax benefit follows from ...
... , , LOS ANGELES, Nov. ... a 40-year-old Indian rhinoceros, has successfully completed treatment for ... to deliver electronic, x-ray based therapy directly to cancer ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091116/SF11909 ) , Randa was ...
Cached Medicine Technology:Cyberonics Provides Update on Tax Position 2Cyberonics Provides Update on Tax Position 3Cyberonics Provides Update on Tax Position 4L.A. Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 2L.A. Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 3
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader ... spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof at ... at the Olympia London, booth #F33 , Be the first to get a sneak ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... speakers for its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly ... as CVS Health, Express Scripts and Milliman, will discuss how plan sponsors are ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Hunters Creek ... Survivor Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited ... for friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
(Date:9/3/2015)... ... 2015 , ... ProScrub is a set of automated tools that allow Final ... speed effects without the use of keyframes. Utilize ProScrub's powerful sliders to determine ... perfect complements to energetic video productions. ProScrub is a Final Cut Pro ...
(Date:9/3/2015)... ... ... an unavoidable result of incision or injury to the skin. Unsightly as it may be, ... of a scar is dependent on many factors – the size and depth of the ... near invisibility on their own over a period of months,” says Dr. Jocelyn Lieb ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4
... , WEDNESDAY, Sept. 21 (HealthDay News) -- How ... they see a pediatrician, dermatologist or internist, a new ... birth to age 18 are affected by psoriasis, a ... flaky, dry skin. Researchers from University of California, ...
... 21, 2011) A soy germ-based nutritional supplement containing ... skin wrinkles of the outer corner of the eyes ... S-equol have potential to slow skin aging, according to ... in the peer-review journal Menopause and presented ...
... America (ASA) will include more than 1,000 presentations in the ... speech; the science of music; the impact of noise on ... irritating impacts the way we learn, work, and play. ... place October 31 - November 4 in San Diego, California, ...
... (HealthDay News) -- Most of the 220,000 people who undergo ... follow-up procedures they could have to remove any loose skin ... surgeons. However, not all patients who undergo so-called ... dramatic weight loss, said one doctor who,s an obesity expert. ...
... whose work is advancing understanding of neurodegenerative diseases, has ... highest honors bestowed on an individual in the United ... of neurology in the UCSF Memory and Aging Center, ... dementia, a family of neurological syndromes usually afflicting ...
... can invade your bloodstream, break into your brain and ... contagious protozoa infect more than half the world,s population, ... Cornell researchers recently discovered how T. gondii ... it the first known parasite to control its host,s ...
Cached Medicine News:Health News:Kids With Psoriasis Get Inconsistent Care 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 3Health News:Acoustical Society meeting: Highlights and media registration 2Health News:Acoustical Society meeting: Highlights and media registration 3Health News:Acoustical Society meeting: Highlights and media registration 4Health News:Acoustical Society meeting: Highlights and media registration 5Health News:Acoustical Society meeting: Highlights and media registration 6Health News:Many Unaware of Plastic Surgery Options After Weight Loss Procedures 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 3Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 4Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 2Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 3
... A new Transnasal Lacrimal Stent has been ... B. Becker, M.D., the Transnasal Lacrimal Stent addressed ... and other forms of endoscopic DCR. Brought in ... relatively large diameter. Because there is no need ...
...
... electrophysiology system is the Espion. This is an ... wide variety of stimulators for different types of ... ,The Espion system was designed from the ... standard clinical visual function tests, ERG, VEP, PERG, ...
... SIREMOBIL Iso-C3D is based on SIREMOBIL ... the industry. In the intra-operative 3D-Mode, the ... the motorized 190 orbital movement. This allows ... in greater precision during the procedure. This ...
Medicine Products: